As of October 4, 2026, Vertex Pharmaceuticals Inc (VRTX) is trading at $504.73. BlackOwl's AI analysis indicates a bullish outlook with 70% confidence and a price target of $582.00 (15.3% above the current price).

V

VRTX

$504.73 bullish

Vertex Pharmaceuticals Inc

Trade
No chart data available for this period

Over a 2-week timeframe, VRTX exhibits positive trend continuation backed by raised full-year guidance and solid technical indicators. The $582.00 target captures potential breakout movement past near-term resistance.

Trend

bullish

Confidence

70%

Price Target

$582.00

+15.3% from current

Timeframe

2 Weeks

Until 9/16/2026

Key Insights

  • Medium-term trend remains firmly positive with prices trading well above both the 20-day and 50-day SMAs
  • Guidance upgrades reinforce fundamental backing for current valuation levels

Risk Factors

  • Analyst estimate revisions have trended downward slightly over the past month
  • Broader biotech sector rotation risks could limit follow-through

Actionable Items

  • Monitor break above the $575 resistance level for acceleration toward $582
  • Reassess positions if prices slip below the 20-day moving average

News Sentiment

News Count

1

Impact Level

medium

Sentiment

Positive

Key Topics

full-year guidance raisecystic fibrosis leadership

Key Statistics

P/E Ratio 29.36x
Forward P/E —
EPS (TTM) —
Beta —
Div. Yield —
ROE 23.54%
ROA 17.12%
ROI 19.82%
52W High —
52W Low —
Dividend —
Market Cap —

New to reading these? Start with how to research stocks.

Related Tickers

L
LLY

Lilly(Eli) & Co

$1,142.85
-0.6%
J
JNJ

Johnson & Johnson

$256.03
-1.0%
A
ABBV

Abbvie Inc

$262.82
+1.1%
M
MRK

Merck & Co Inc

$144.30
+0.3%
U
UNH

Unitedhealth Group Inc

$371.90
+1.8%

Frequently Asked Questions

What is Vertex Pharmaceuticals Inc's current stock price?
As of October 4, 2026, Vertex Pharmaceuticals Inc (VRTX) is trading at $504.73 per share. This is AI-generated analysis for informational purposes only, not financial advice.
What does BlackOwl's AI model project for VRTX?
BlackOwl's model reads VRTX as bullish in the medium term with 70% confidence, with a price target of $582.00 — 15.3% above the current price of $504.73. This is AI-generated analysis for informational purposes only, not financial advice.
What is VRTX's P/E ratio?
Vertex Pharmaceuticals Inc has a price-to-earnings (P/E) ratio of 29.36x. This is above the market average, which typically reflects higher growth expectations. This is AI-generated analysis for informational purposes only, not financial advice.
How do I buy VRTX stock?
You can buy Vertex Pharmaceuticals Inc (VRTX) directly through BlackOwl with one click. Sign up for a free account, connect your brokerage, and trade instantly. This is AI-generated analysis for informational purposes only, not financial advice.

Get AI-powered insights for VRTX

Unlock real-time signals, personalized risk analysis, and trade recommendations.

Try BlackOwl Free